News Focus
News Focus
Followers 212
Posts 6120
Boards Moderated 1
Alias Born 01/07/2015

Re: trding post# 105

Thursday, 01/07/2021 1:27:53 AM

Thursday, January 07, 2021 1:27:53 AM

Post# of 2109
$gbnt, 23c, 8day 21c, otcqb


With the recent price history with several resistance points between here and $1, I wouldn't but it on the dlu list yet, but it does look very interesting to me as far as potential. It could be at the beginning of a bullish trend. If the price can close above 28c, you might have a new uptrend started. It has been in a long overall downtrend since February starting at $1.65. It will be interesting to see what happens over the next few days.

OS 109M, float 94m
forward split 1.4:1 2/20
forward split 21:1 11/18
reverse split 1:1000 3/17










Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today